Znn3bq.jpeg
ÉÇÍ·´óѧº£Ñó¿ÆÑ§½ÓÊܵ÷¼Á
²é¿´: 16765  |  »Ø¸´: 77
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

guohuicpu

Òø³æ (СÓÐÃûÆø)


[½»Á÷] ¡¾×ªÌû¡¿Ò©Æ·²éÑ¯ÍøµÄÊý¾Ý¿â ÒÑÓÐ72È˲ÎÓë

Ò©ÎïÊý¾Ý¿â¡¡¡¡±¾ÌõÄ¿ÁгöÁËһЩ³£¼ûµÄÃâ·ÑÒ©ÎïÊý¾Ý¿â[1]
¡¡¡¡£¨ÐÅÏ¢³ö´¦Îª£ºÃÀ¹úMedKoo Biosciences, Inc.¹«Ë¾µÄ¹Ù·½ÍøÒ³£ºÆäÍøÕ¾µØÖ·Îª£º http://www.medkoo.com£©
¡¡¡¡1. ÃÀ¹úFDAÒ©Æ·Êý¾Ý¿â£º
¡¡¡¡ÆäÍøÖ·Îª: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/. Õâ¸öÊý¾Ý¿âÊÕ¼¯ÁËÃÀ¹úÉÏÊеÄËùÓÐÒ©Æ·É걨×ÊÁÏ. »ù±¾¼ìË÷·½·¨¿ÉÒÔʹÓÃÐÂÒ©ÉêÇëºÅ (New drug applicationnumber, NDA number), Ò©Æ·»îÐԳɷÖÃû (Active Ingredient), Ò©Æ·ÉÌÆ·Ãû (Drug Name) µÈ¼¸ÖÖ·½·¨À´¼ìË÷. ¸ß¼¶µÄ¼ìË÷·½·¨°üº¬ÁËÉÏÊö»ù±¾¼ìË÷·½·¨ÔÙ¼ÓÉÏʱ¼ä²ÎÊý.
¡¡¡¡2. ÃÀ¹úFDAÒ©Æ·¡± ³ÈÉ«Êý¾Ý¿â¡±(Electronic Orange Book)
¡¡¡¡ÆäÍøÖ·Îª: http://www.fda.gov/cder/ob/default.htm. ±¾Êý¾Ý¿âº¬ÓÐÒ©ÎïµÈЧÐÔÆÀ¼ÛÐÅÏ¢,°üÀ¨ËùÓÐÒÑÅú×¼µÄÒ©Æ·. Æä»ù±¾¹¦ÄÜÓëFDAµÄÉÏÊÐÒ©Æ·Êý¾Ý¿âÏàËÆ, ¿ÉÒÔʹÓÃÐÂÒ©ÉêÇëºÅ (New drug application number, NDA number), Ò©Æ·»îÐԳɷÖÃû (Active Ingredient),, Ò©Æ·ÉÌÆ·Ãû (Drug Name), Ò©Æ·É걨»ú¹¹Ãû(Applicant holder), ҩƷרÀûºÅµÈ¼¸ÖÖ·½·¨À´¼ìË÷. ÔÚÐÂÒ©ÉêÇëºÅ, Ò©Æ·»îÐԳɷÖÃû, Ò©Æ·ÉÌÆ·Ãû, Ò©Æ·É걨»ú¹¹ÃûµÄÑ¡ÏîÏÂ,ÿÖмìË÷·½·¨¹ý°üº¬ÁË¡±´¦·½Ò©¡±,¡±·Ç´¦·½Ò©¡±(OTC), ¡°Í£Ö¹ÉÏÊÐÒ©¡±ÈýÖÖÑ¡ÔñÏî.
¡¡¡¡3. ÃÀ¹úFDAÉÏÊÐÒ©Æ·¼ìË÷ϵͳ£¨FDA Drug Index Database£©
¡¡¡¡ÕâÊÇÖйúÒ©ÎïÔÚÏßÍø£¨ http://www.drugfuture.com£©ÍƳöµÄFDAÉÏÊÐ Ò©Æ·¼ìË÷ƽ̨¡£¸ÃÊý¾Ý¿â°üº¬FDAµ½Ä¿Ç°ÎªÖ¹ÒÑÉÏÊлòÔø¾­ÉÏÊеÄÈ«²¿Ò©Æ·£¬°ïÖúÄú¿ìËÙ»ñ֪ijҩƷ¼°Ïà¹ØÒ©Æ·ÔÚÃÀ¹ú×¢²á¡¢ÉóÅú¡¢×¨ÀûµÈ·½ÃæµÄÖØÒªÐÅÏ¢¡£ÆäÍø Ò³ÊÇ£º http://www.drugfuture.com/fda/db1_query.asp¡£ÆäÌØµãÊÇ£º
¡¡¡¡1¡¢Ö§³ÖÄ£ºý²éѯºÍ×éºÏ²éѯ,¸÷Ìõ¼þ¼ä¹ØÏµÎªÂß¼­Óë¡£ÀýÈçÔÚÒ©Æ·ÉÌÆ·ÃûÖÐÊäÈëLevofloxacin£¬¼´¿É²éѯËùÓÐÔÚÃÀ¹úÉÏÊеÄ×óÑõ·úɳÐÇÆ·ÖÖ¡£
¡¡¡¡2¡¢ÓÐЧ³É·ÖºÍÉÌÆ·Ãû²»ÄÜÉÙÓÚ3¸ö×Ö·û£¬ÐÂÒ©ÉêÇëºÅΪ6λÊý×Ö£¬¸ñʽΪnnnnnn¡£¸÷¼ìË÷Ìõ¼þÒâÒåÈçÏ£º
¡¡¡¡*ҩƷͨÓÃÃû»òÓÐЧ³É·Ö£ºDrug generic name\Active ingredient¡£
¡¡¡¡*ҩƷרÀûÒ©Ãû»òÉÌÆ·Ãû: Brand name¡£
¡¡¡¡*Ò©Æ·×¢²áÉêÇëºÅ£ºApplication number¡£
¡¡¡¡*Ò©Îï¼ÁÐÍ»ò¸øÒ©Í¾¾¶osage form\route of administration
¡¡¡¡3¡¢¼ìË÷½á¹û°üÀ¨£º
¡¡¡¡*ÉÌÆ·Ãû(Ó¢ÎÄÃû)¡¢ÓÐЧ³É·Ö¡¢¼ÁÐÍ¡¢¹æ¸ñ¡¢ÉêÇëºÅ¡¢²úÆ·ºÅ¡¢Êг¡×´Ì¬¡¢TE´úÂë¡¢Åú×¼ÈÕÆÚ¡¢RLD´úÂë¡¢Ò©Æ·Àà±ð¡¢ÉêÇë»ú¹¹¡£
¡¡¡¡*¸ÃÒ©Æ·µÄÃÀ¹úרÀûºÅ£¬×¨ÀûʧЧÈÕÆÚ¡¢×¨ÀûÀà±ð£¬²¢¿ÉÖ±½ÓÒ»´ÎÐÔÍêÕûÏÂÔØ×¨ÀûÈ«ÎÄ£¬¸ñʽΪPDF»òTIFÁ½ÖÖ¡£
¡¡¡¡*Êг¡¶ÀռȨ±£»¤Çé¿ö£¬º¬¶ÀռȨÀàÐͼ°Ê§Ð§ÈÕÆÚ¡£
¡¡¡¡*Ò©Æ·×¢²áÉóÅúÐÅÏ¢£¬º¬È«²¿ÀúÊ·ÉóÅúÊý¾Ý£¬ÉóÅúʱ¼ä¡¢ÉóÅúÀà±ð¡¢Ò©Æ·ËµÃ÷Êé¡¢×ÛÊö¡¢Í¨Öª¼þµÈ¡£
¡¡¡¡4. PHRMAÁÙ´²Ñо¿ÖеÄÒ©ÎïÊý¾Ý¿â( http://newmeds.phrma.org/index.p ... pany=&status=3)
¡¡¡¡Today, over 2,000 newmedicines are in development. Many of these potential new medicines will failin clinical trials, but some may represent tomorrow's new treatments. Bringingeach new medicine to patients will require, on average, 10-15 years of testingand review. This database includes medicines currently in clinical trials or atFDA for review. The information contained in this database was derived fromWolters Kluwer Health's Adis R&D Insight and is published with permissionunder license with Wolters Kluwer Health. PhRMA has not reviewed or verifiedthis information.
¡¡¡¡5. ÁÙ´²Ñз¢ÖеÄÐÂÒ©Ë÷ÒýInfoknowmics™( http://www.infoknowmics.com/DrugIndex.html)
¡¡¡¡This index lists over 8900distinct drugs for the treatment and/or prevention of human diseases andmedical conditions. These products are part of our Infoknowmics™ Knowledgebasebecause they disclosed development activity in the past 9 years. The indexincludes all types of drugs across all clinical indications. It includes drugsthat are currently in the discovery, preclinical or clinical stages ofdevelopment, drugs that have been approved and launched during this timeperiod, as well those that have been discontinued.
¡¡¡¡For each product, we listits various names including the proprietary name (also called the brand name ortrade name), which is usually followed the trademark (™ or registeredtrademark (® symbol. In addition, we provide the generic name (recommended orapproved by international and US nomenclature committees), as well as anyaliases which are typically laboratory code names, or new names assigned by alicensee or co-developer.
¡¡¡¡The type of each product isalso given. This category includes traditional product types, such as drugs,antibiotics, vaccines, and hormones, as well as newer types of products such asmonoclonal antibodies and other types of recombinant proteins, celltherapeutics, gene therapy, DNA vaccines, antisense, and RNA interference-basedproducts.
¡¡¡¡Each product is indexed to its Originator Company, for intellectual property purposes. Please note thatbecause out-licensing, co-development or other types of partnerships may existfor each product, the Originator Company may not be the company currentlydeveloping the drug. The index was last updated on April 2, 2007 and can beviewed by Product Name or Product Type.
¡¡¡¡6. Ò©Îï·Ç»îÐԳɷÖÊý¾Ý¿â£¨Inactive Ingredient Searchfor Approved Drug Products£©
¡¡¡¡ÕâÊÇÖйúÒ©ÎïÔÚÏßÍø£¨ http://www.drugfuture.com£©ÍƳöµÄÃÀ¹úFDA Åú×¼Ò©Îï·Ç»îÐԳɷÖÊý¾Ý¿â.1¡¢±¾Êý¾Ý¿âΪFDAÅú×¼Ò©ÎïËùʹÓõķǻîÐԳɷÖÊý¾Ý¿â£¬¼´FDAÉÏÊвúÆ·Öаüº¬µÄ¸¨ÁÏÐÅÏ¢Êý¾Ý¡£2¡¢¼ìË÷Ìõ¼þÖ§³ÖÄ£ºý²éѯ£¬ ¸÷ÊäÈëÌõ¼þ¼äµÄ¼ìË÷¹ØÏµÎªÂß¼­Ó루¼´AND¹ØÏµ£©¡£ 3¡¢¼ìË÷½á¹û°üÀ¨£º·Ç»îÐԳɷÖÃû³Æ¡¢¸øÒ©Í¾¾¶»ò¼ÁÐÍ¡¢CASµÇ¼ÇºÅ¡¢ÃÀ¹úÒ©µä/FDAÎïÖʵǼÇϵͳΨһ±êʶÂë¡¢´¦·½Öи¨ÁÏʹÓÃÁ¿¡£4¡¢ÀûÓñ¾Êý¾Ý¿â¿ÉÒÔΪҩÎïÑо¿¿ª·¢ÕßÌṩ¸¨ÁϵݲȫÓÃÁ¿µÄÊÂʵÐÔÊý¾Ý¡£¼ìË÷·½·¨°üÀ¨£º
¡¡¡¡*·Ç»îÐԳɷÖÃû³Æ(Inactive Ingredient)£»
¡¡¡¡*¸øÒ©Í¾¾¶»ò¼ÁÐÍ(Route; Dosage Form)£»
¡¡¡¡*CASµÇ¼ÇºÅ(CAS Number)£»
¡¡¡¡*Ψһ±êʶÂë(Unique Ingredient Identifier)
¡¡¡¡7. ¼ÓÄôóÒ©ÎïÒøÐÐ http://lims.drugbank.ca
¡¡¡¡ÆäÍøÖ·Îª: http://lims.drugbank.ca/.¸ÃÊý¾Ý¿âº¬ÓÐÒ©Æ·µÄ»¯Ñ§,ÉúÎï×Ê ÁÏ, °üÀ¨Ò©Îï×÷ÓûúÖÆ, Ò©Æ·×÷ÓÃÊÜÌåÄ¿±ê. ¹²ÓÐ4300¶à¸öÒ©Îï. ÆäÖÐFDAÅú×¼µÄС·Ö×ÓÒ©ÎïÓÐ1200¶à¸ö, ÉúÎïÒ©ÎïÓÐ113¸ö. ÓªÑø¸¨ÖúÒ©Îï62¸ö, ÕýÔÚÁÙ´²ÊÔÑéµÄÒ©Îï3000¶à¸ö.
¡¡¡¡8. ÃÀ¹ú´¦·½Ò©Ë÷ÒýÍø, ÃÀ¹úÒ©Æ·Íø
¡¡¡¡ÕâÁ½¸öÍøÕ¾µÄÍøÖ··Ö±ðÊÇ£º http://www.rxlist.com/ ºÍ http://www.drugs.com£¬ÊôÓÚ´óÐ͵ÄҩƷ˵Ã÷Êé¼°Ò½Ò©, ÎÀÉú, ±£½¡ÖªÊ¶½éÉÜÍøÕ¾. ÄÚº¬´óÁ¿ÓйØÒ©Æ·µÄÐÅÏ¢
¡¡¡¡9. ÖйúÒ©ÍøµÄҩƷ˵Ã÷Êé:
¡¡¡¡ÆäÍøÖ·Îª: http://www.chinapharm.com.cn/html/database/drugmanual/¸ÃÍøÕ¾ÊÕ¼¯Á˺ܶàҩƷ˵Ã÷Êé, ÆäҩƷ˵Ã÷ÊéµÄÍøÕ¾Ê×Ò³ÓÐÒ©Æ·µÄ·ÖÀàºÍÒ©Æ·¼ìË÷¹¦ÄÜ, ʹÓÃÆðÀ´ºÜ·½±ã. ´ËÍâ¸ÃÍøÕ¾»¹ÓÐÆäËûÓÐÓÃ×ÊÁÏÈç: Êг¡ÐÅÏ¢. Ò©Æ·ÐÂÎźÍÕþ¸®·¨¹æµÈ
¡¡¡¡10. Öйú¹ú¼ÒʳƷҩƷ¼à¶½¹ÜÀí¾Ö
¡¡¡¡ÆäÍøÒ³Îª£º http://www.sfda.gov.cn/WS01/CL0001/¡£ÕâÊÇÖйú¹ú¼ÒʳƷҩƷ¼à¶½¹ÜÀí¾ÖµÄÊý¾Ý¿âÈëÃÅÍøÒ³. Ö÷Òª°üº¬ÈçÏÂÄÚÈÝ:
¡¡¡¡*OTC»¯Ñ§Ò©Æ·ËµÃ÷Êé·¶±¾
¡¡¡¡*OTCÖÐҩ˵Ã÷Êé·¶±¾
¡¡¡¡*ִҵҩʦÈ϶¨Ãûµ¥
¡¡¡¡*Ò©°ü²ÄÉú²úÆóÒµÊý¾Ý¿â
¡¡¡¡*È«¹ú³·ÏúµÄÒ©Æ·¹ã¸æ
¡¡¡¡*ÉêÇëÈËÉ걨ÊÜÀíÇé¿ö
¡¡¡¡*Åú×¼µÄÒ©°ü²ÄÊý¾Ý¿â
¡¡¡¡*ÉÏÉýΪ¹ú¼Ò±ê×¼µÄÒ©Æ·Ãûµ¥
¡¡¡¡*Åú×¼ÁÙ´²Ñо¿µÄÐÂÒ©
¡¡¡¡*Ò©Æ·×¢²áÊÜÀíÐÅÏ¢
¡¡¡¡*Ò©Æ·×¢²áÅú×¼ÐÅÏ¢
¡¡¡¡*¿É·¢²¼´¦·½Ò©¹ã¸æµÄҽѧҩѧרҵ¿¯ÎïÃûµ¥
¡¡¡¡*Ò©Æ·×¢²áÅú¼þ·¢ËÍÐÅÏ¢
¡¡¡¡*¹ú¼Ò»ù±¾Ò©Î2004Ä꣩
¡¡¡¡*Ô¤·ÀÀàÉúÎïÖÆÆ·ËµÃ÷Êé
¡¡¡¡*Ò½ÁÆÆ÷е¼ì²âÖÐÐÄÊܼìĿ¼
¡¡¡¡*Ò©ÎïÁÙ´²ÊÔÑé»ú¹¹Ãûµ¥
¡¡¡¡*Ò½ÁÆÆ÷е·ÖÀàĿ¼ Ò½ÁÆÆ÷е±ê׼Ŀ¼
¡¡¡¡*ÁÙ´²Ç°Ñо¿µ¥Î»±¸°¸Ãûµ¥
¡¡¡¡*È«¹ú³·Ïú±£½¡Æ·¹ã¸æ
¡¡¡¡11. ά»ù°Ù¿ÆÈ«Êé:
¡¡¡¡ÆäÍøÖ·Îª: http://www.wikipedia.com.ά»ù°Ù¿ÆÊÇÒ»¸ö»ùì¶wiki¼¼ÊõµÄ¶àÓïÑԵİٿÆÈ«ÊéЭ×÷¼Æ»®£¬Ò²ÊÇÒ»²¿Óò»Í¬ÓïÑÔд³ÉµÄ°Ù¿ÆÈ«Ê飬ÆäÄ¿±ê¼°×ÚÖ¼ÊÇΪµØÇòÉϵÄÿһ¸öÈËÌṩ×ÔÓɵİٿÆÈ«Êé ¡ª¡ªÓÃËûÃÇÑ¡ÔñµÄÓïÑÔËùÊéдµÄ£¬È«ÊÀ½ç֪ʶµÄ×ܺ͡£Î¬»ù°Ù¿ÆÈ«Ê飬×Ô2001Äê1ÔÂ15ÈÕÕýʽ³ÉÁ¢£¬ÓÉά»ùýÌå»ù½ð»á¸ºÔðά³Ö£¬½ØÖÁ2007Äê8Ô£¬Î¬»ù °Ù¿ÆÌõÄ¿ÊýµÚÒ»µÄÓ¢ÎÄά»ù°Ù¿ÆÒÑÓÐ190Íò¸öÌõÄ¿£¬¶øËùÓÐ253ÖÖÓïÑԵİ汾¹²Í»ÆÆ800Íò¸öÌõÄ¿. ´ó²¿·ÖÒ³Ãæ¶¼¿ÉÒÔÓÉÈκÎÈËʹÓÃä¯ÀÀÆ÷½øÐÐÔÄÀÀ¼°ÐÞ¸Ä. ËäÈ»ÓÐѧÕß»³ÒÉÆäÄÚÈݵÄ׼ȷÐԺͿÆÑ§ÐÔ£¬µ«´ó²¿·ÖÄÚÈÝ»¹ºÜÊܿ϶¨µÄ. ÖÐÎÄά»ù°Ù¿Æì¶2002Äê10ÔÂ24ÈÕÕýʽ³ÉÁ¢.

[ Last edited by guohuicpu on 2011-2-26 at 14:43 ]

²¢·ÇÔ­´´£¬lzתÌû~
×ÊÔ´½ÏºÃ£¬ÖµµÃ¹ÄÀø

[ Last edited by ´ÓÍ·¿ªÊ¼ on 2012-2-1 at 08:56 ]
»Ø¸´´ËÂ¥

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

ÐÂÒ©Ñз¢Ö¸µ¼ ¡®Ò©Îï¡¢ÓлúºÏ³ÉÑо¿Ô±¡¯×ÊÁÏ´óÈ« ·ÂÖÆÒ©Ñз¢É걨 Ò©ÎïÑз¢ÖªÊ¶
ÍõÊϺϳÉ×ÊÔ´Óë½»Á÷ ÐÂÒ©Ñо¿ »¯Ñ§ÍøÕ¾ ÁÙ´²Ò©Ñ§Ïà¹Ø
ÐÂÒ©·¢ÏÖ ÐÄÁéµÄ¸ÐÎò ÓÅÐã×ÊÔ´Ìû¼­ Ô­ÁÏÒ©
»¯Ñ§¹¤ÒÕÑз¢ ÐÂÒ©Ñз¢ רҵÊý¾Ý¿â½éÉÜ ÐÂÒ©Ñз¢Ñ§Ï°×ÊÁÏ»ã×Ü
Ò©ÑÐÎöÒÉ ÐÂÒ©×ÊѶ ÐÂÒ©¼ìË÷ Ò½Ò©Ñз¢»ù´¡ÖªÊ¶
ÐÂÒ©Ñз¢ÓëÉ걨 Ò©ÎïÑз¢ ÎáÖ®µÀ ¡ï¡þÐÂÒ©Ñз¢¡þ¡ï
רÀûÎÄÏײéÑ¯ÍøÖ· Ò©Ò©Ò© ¹¤×÷Ö®Óà ÐÂÒ©Ñз¢»ù´¡
Ô­ÁÏÒ©¿ª·¢¹¤ÒÕ °®ÎÒËù°® ÓлúºÏ³ÉÏà¹Ø °®Éú»î£¬°®¿ÆÑÐ
ÔÓ»õ ÐÂÒ©Ñз¢ ҩѧ Ò©Æ·Á¢Ïî
ÉúÎïÒ½Ò© ¿ªÐÄ֪ʶÁÔÎï³§---- ÃÀ¹úÅ·ÃËÐÂÒ©ÉóÆÀ ¹¤¾ß
ҩѧÑз¢ Ò©Îï·ÖÎö ¿ñ±¼µÄÎÏÅ£ ·ÂÖÆÒ©Ñз¢

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lvweijie-1

Òø³æ (³õÈëÎÄ̳)

лл£¬ºÜÓÐÓõĶ«Î÷
7Â¥2011-02-28 14:32:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 78 ¸ö»Ø´ð

dinglino1

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
¸Ðл¥Ö÷¾«ÐÄÕûÀíºÍ·ÖÏí£¬ºÜ²»´í£¬ÊÕ²ØÁË£¡
´ÓÍ·ÔÙÀ´
2Â¥2011-02-26 21:18:08
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hebo7104

ľ³æ (СÓÐÃûÆø)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Â¥Ö÷·Ç³£ÓÐÐÄ£¬ÊÕ¼¯µÃ²»´í£¬Ð»Ð»·ÖÏí£¡
3Â¥2011-02-28 08:03:22
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

¾µ×Ó2180

½ð³æ (ÖøÃûдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
лл¥Ö÷£¬ÐÁ¿à£¬ÊÕ²ØÁË¡£
4Â¥2011-02-28 08:21:56
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 291 Çóµ÷¼Á +36 »¯¹¤2026½ì±ÏÒµÉ 2026-04-09 36/1800 2026-04-14 13:20 by µÚÒ»ÌìºÃ
[½Ìʦ֮¼Ò] ת³¤Æ¸ÁË +6 ¼òµ¥»¯xn 2026-04-13 6/300 2026-04-14 11:13 by jayone1989
[¿¼ÑÐ] »úе¹¤³Ì313·ÖÕÒ¹¤¿Æµ÷¼Á +4 ˫һÁ÷±¾¿Æ»úе 2026-04-08 4/200 2026-04-14 07:32 by Abskk
[¿¼ÑÐ] 293Çóµ÷¼Á +16 ÎÒ°®¸ßÊý¸ßÊý°®Î 2026-04-12 18/900 2026-04-13 21:47 by ѧԱJpLReM
[¿¼ÑÐ] Ò»Ö¾Ô¸2110£¬»¯Ñ§Ñ§Ë¶310·Ö£¬±¾¿ÆÖصãË«·ÇÇóµ÷¼Á +20 ŬÁ¦·Ü¶·112 2026-04-08 20/1000 2026-04-13 14:24 by ÕÅzhihao
[¿¼ÑÐ] һ־Ը³¶«´óѧ071000ÉúÎïѧѧ˶³õÊÔ·ÖÊý276Çóµ÷¼Á +8 Ľ¾øcc 2026-04-09 8/400 2026-04-13 14:08 by ÕÅzhihao
[¿¼ÑÐ] 0831Ò»ÂÖµ÷¼Áʧ°ÜÇóÖú +10 СÐÜî£î£_s 2026-04-11 10/500 2026-04-12 22:43 by ³¤¹­°Á
[¿¼ÑÐ] 086000µ÷¼Á +6 Ê®Æßsa 2026-04-07 6/300 2026-04-12 11:05 by ´óÁ¦Ë®ÊÖÁ¦´óÎÞÇ
[¿¼ÑÐ] Çóµ÷¼Á£¬262»úеר˶ +8 àÅyyl 2026-04-08 8/400 2026-04-12 02:31 by Çï¶¹²ËÑ¿
[¿¼ÑÐ] 277 ÊýÒ»104£¬Ñ§Ë¶£¬Çóµ÷¼Á +21 Æ¿×ÓPZ 2026-04-09 23/1150 2026-04-11 23:12 by labixiaoqiao
[¿¼ÑÐ] 11408¡£358Çóµ÷¼Á +3 TMYzds 2026-04-07 3/150 2026-04-11 17:10 by µªÆøÆøÆø
[¿¼ÑÐ] 337Çóµ÷¼Á +4 ÑÐs. 2026-04-10 4/200 2026-04-11 08:57 by zhq0425
[¿¼ÑÐ] 085506-Çóµ÷¼Á-285·Ö +3 À×Å··ÉÌß 2026-04-08 3/150 2026-04-11 08:37 by zhq0425
[¿¼ÑÐ] 263ÄÜÔ´¶¯Á¦×¨Ë¶Çóµ÷¼Á +3 ¼Ó´óºÅ·¹ºÐ´ü 2026-04-10 3/150 2026-04-10 22:23 by 286640313
[¿¼ÑÐ] 309Çóµ÷¼Á +14 wdhw 2026-04-10 15/750 2026-04-10 21:06 by zhouxiaoyu
[¿¼ÑÐ] 368Çóµ÷¼Á +3 17385968172 2026-04-10 3/150 2026-04-10 20:12 by µç×Ӱµ±ë
[¿¼ÑÐ] 367Çóµ÷¼Á +10 hffQAQ 2026-04-09 10/500 2026-04-09 18:06 by lijunpoly
[¿¼ÑÐ] 085400µç×ÓÐÅÏ¢Àࣨ´¨´ó¿ØÖƹ¤³Ì£©Çóµ÷¼Á¿É¿çרҵ ÇóÀÏʦÁªÏµ +3 626776879 2026-04-08 3/150 2026-04-09 16:05 by Öí»á·É
[¿¼ÑÐ] 085404£¬334·Ö£¬Çóµ÷¼Á +5 sunjie8888 2026-04-08 8/400 2026-04-09 07:26 by sunjie8888
[¿¼ÑÐ] 11408 325·Ö +3 jgtxuxgkx 2026-04-07 3/150 2026-04-07 23:10 by lbsjt
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û